COMPARISON OF THE KARYDAKIS FLAP PROCEDURE AND THE LIMBERG FLAP PROCEDURE IN THE TREATMENT OF SACROCOCCYGEALL LOCALIZED PILONIDAL SINUS DISEASE
Abstract
Objective: To compare the outcome of Limberg flap versus Karydakis flap for treatment of sacrococcygeal localized pilonidal sinus disease.
Study Design: Randomized controlled trial
Study p1ace and period: Department of Surgery, Rawalpindi Teaching Hospital, Rawalpindi from July 2025 to November 2025.
Methodology: Total seventy patients were included and randomized into 2 surgical groups. In group A, limberg flap was applied. In group B, patients Karydakis flap was applied. Surgical time was noted. Total hospital stay was also recorded. Patients were also evaluated for complete wound healing and complications including fluid collection, infection, and recurrence necrosis. Data will be recorded in proforma. Data was analyzed in SPSS v.25. Both surgical groups were compared for mean surgical time, hospital stay and days required for complete wound healing by applying independent samples t-test and for complications by applying chi-square test, keeping P≤ 0.05 as significant.
Results: The mean age of individuals in Limberg flap group was 45.54 ± 19.73 years and in Karydakis flap group was 58.31 ± 14.34 years. In limberg flap group, there were 23 (65.7%) males and 12 (34.3%) females. In Karydakis flap group, there were 25 (71.4%) males and 10 (28.6%) females. In limberg flap group, the mean surgical time was 44.54 ± 11.11 min and in karydakis flap group was 36.29 ± 8.66 min (p=0.001). The mean hospital stay was 3.00 ± 0.77 days vs. 1.57 ± 0.50 days, mean duration of wound healing was 24.37 ± 4.86 days vs. 18.46 ± 2.65 days, fluid collection was observed in 12 (34.3%) vs. 3 (8.6%) individuals, infection in 11 (31.4%) vs. 2 (5.7%) while recurrence in 5 (14.3%) vs. nil (0%), respectively.
Conclusion: The outcomes of Karydakis flap group was better than Limberg flap group.
Downloads
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.